Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 49,652Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 138Amgen Inc

02 30Dompe Farmaceutici

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 25UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 40UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 60UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 100UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 200UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; SUBCUTANEOUS

Dosage Strength : 25UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; SUBCUTANEOUS

Dosage Strength : 40UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; SUBCUTANEOUS

Dosage Strength : 60UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; SUBCUTANEOUS

Dosage Strength : 100UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; SUBCUTANEOUS

Dosage Strength : 200UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

11

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Darbepoetin Alfa

Brand Name : Aranesp

Dosage Form : Solution For Injection

Dosage Strength : 10mcg

Packaging :

Approval Date : 28/02/2005

Application Number : 20041018000150

Regulatory Info : Approved

Registration Country : Sweden

blank

12

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Darbepoetin Alfa

Brand Name : Aranesp

Dosage Form : Solution For Injection

Dosage Strength : 10mcg

Packaging :

Approval Date : 08/06/2001

Application Number : 20010608000078

Regulatory Info : Approved

Registration Country : Sweden

blank

13

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Darbepoetin Alfa

Brand Name : Aranesp

Dosage Form : Injectable Solution

Dosage Strength : 100mcg

Packaging :

Approval Date : 28/02/2011

Application Number : 20100730000142

Regulatory Info : Approved

Registration Country : Sweden

blank

14

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Darbepoetin Alfa

Brand Name : Aranesp

Dosage Form : Solution For Injection

Dosage Strength : 100mcg

Packaging :

Approval Date : 28/02/2005

Application Number : 20041018000235

Regulatory Info : Approved

Registration Country : Sweden

blank

15

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Darbepoetin Alfa

Brand Name : Aranesp

Dosage Form : Solution For Injection

Dosage Strength : 100mcg

Packaging :

Approval Date : 08/06/2001

Application Number : 20010608000054

Regulatory Info : Approved

Registration Country : Sweden

blank

16

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Darbepoetin Alfa

Brand Name : Aranesp

Dosage Form : Solution For Injection

Dosage Strength : 130mcg

Packaging :

Approval Date : 02/05/2007

Application Number : 20070112000087

Regulatory Info : Approved

Registration Country : Sweden

blank

17

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Darbepoetin Alfa

Brand Name : Aranesp

Dosage Form : Solution For Injection

Dosage Strength : 130mcg

Packaging :

Approval Date : 02/05/2007

Application Number : 20070112000094

Regulatory Info : Approved

Registration Country : Sweden

blank

18

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Darbepoetin Alfa

Brand Name : Aranesp

Dosage Form : Solution For Injection

Dosage Strength : 15mcg

Packaging :

Approval Date : 28/02/2005

Application Number : 20041018000167

Regulatory Info : Approved

Registration Country : Sweden

blank

19

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Darbepoetin Alfa

Brand Name : Aranesp

Dosage Form : Solution For Injection

Dosage Strength : 15mcg

Packaging :

Approval Date : 08/06/2001

Application Number : 20010608000085

Regulatory Info : Approved

Registration Country : Sweden

blank

20

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Darbepoetin Alfa

Brand Name : Aranesp

Dosage Form : Solution For Injection

Dosage Strength : 150mcg

Packaging :

Approval Date : 28/02/2005

Application Number : 20041018000242

Regulatory Info : Approved

Registration Country : Sweden

blank